China SXT Pharmaceuticals, Inc.

NasdaqCM:SXTC Stock Report

Market Cap: US$1.4m

China SXT Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SXTC?
Owner TypeNumber of SharesOwnership Percentage
Institutions46,8401.35%
Individual Insiders410,04211.8%
General Public3,019,20986.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 514.7%.


Top Shareholders

Top 10 shareholders own 13.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.7%
John Fife
405,837US$158.3k0%no data
0.44%
Baader Bank AG, Asset Management Arm
15,161US$5.9k0%no data
0.35%
GSA Capital Partners LLP
12,300US$4.8k0%no data
0.29%
BMO Asset Management Corp.
10,000US$3.9k0%no data
0.25%
UBS Asset Management AG
8,678US$3.4k-31%no data
0.12%
Feng Zhou
4,205US$1.6k0%no data
0.011%
Acadian Asset Management LLC
379US$147.8-86.3%no data
0.011%
JPMorgan Chase & Co, Brokerage and Securities Investments
376US$146.70%no data
0.0013%
Avanza Fonder AB
45US$17.5-99.8%no data
0.00003%
BCV Asset Management
1US$0.40%no data